HomeCompareXBIOW vs FCPT

XBIOW vs FCPT: Dividend Comparison 2026

XBIOW yields 11.40% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FCPT wins by $6.6K in total portfolio value· pulled ahead in Year 8
10 years
XBIOW
XBIOW
● Live price
11.40%
Share price
$17.54
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$42.5K
Annual income
$2,326.31
Full XBIOW calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — XBIOW vs FCPT

📍 FCPT pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodXBIOWFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, XBIOW + FCPT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
XBIOW pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XBIOW
Annual income on $10K today (after 15% tax)
$969.21/yr
After 10yr DRIP, annual income (after tax)
$1,977.36/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, FCPT beats the other by $2,931.62/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XBIOW + FCPT for your $10,000?

XBIOW: 50%FCPT: 50%
100% FCPT50/50100% XBIOW
Portfolio after 10yr
$45.8K
Annual income
$4,050.80/yr
Blended yield
8.85%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

XBIOW
No analyst data
Altman Z
-29.7
Piotroski
3/9
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XBIOW buys
0
FCPT buys
0
No recent congressional trades found for XBIOW or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricXBIOWFCPT
Forward yield11.40%6.05%
Annual dividend / share$2.00$1.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$42.5K$49.1K
Annual income after 10y$2,326.31$5,775.28
Total dividends collected$17.2K$24.1K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: XBIOW vs FCPT ($10,000, DRIP)

YearXBIOW PortfolioXBIOW Income/yrFCPT PortfolioFCPT Income/yrGap
1$11,840$1,140.25$11,401$700.92+$439.00XBIOW
2$13,931$1,261.76$13,064$864.84+$867.00XBIOW
3$16,293$1,387.43$15,051$1,072.48+$1.2KXBIOW
4$18,951$1,516.57$17,442$1,337.22+$1.5KXBIOW
5$21,926$1,648.49$20,340$1,677.08+$1.6KXBIOW
6$25,243$1,782.51$23,880$2,116.57+$1.4KXBIOW
7$28,928$1,917.94$28,241$2,689.36+$687.00XBIOW
8← crossover$33,007$2,054.14$33,660$3,442.07$653.00FCPT
9$37,508$2,190.46$40,456$4,439.95$2.9KFCPT
10$42,460$2,326.31$49,063$5,775.28$6.6KFCPT

XBIOW vs FCPT: Complete Analysis 2026

XBIOWStock

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. In addition, the company leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, and PJSC Pharmsynthez. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.

Full XBIOW Calculator →

FCPTREIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this XBIOW vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XBIOW vs SCHDXBIOW vs JEPIXBIOW vs OXBIOW vs KOXBIOW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.